INDIVIDUALIZED HOMOEOPATHIC MANAGEMENT OF CHRONIC SCALP ERUPTIONS WITH MARKED FLAKING AND PRURITUS: A CASE REPORT AT DR BATRA’S
DOI:
https://doi.org/10.5281/zenodo.22032127Keywords:
Scalp psoriasis; scalp scaling; pruritus; individualized homoeopathy; Calcarea carbonica; case report.Abstract
BackgroundChronic inflammatory scalp disorders characterized by erythema, scaling, flaking and pruritus can have a substantial impact on comfort and quality of life. Scalp psoriasis is primarily a clinical diagnosis, and its presentation may overlap with other scaling disorders of the scalp. (NICE)
Case PresentationA 14-year-old female student presented with white patches over the scalp associated with profuse, powdery, flaky dandruff and itching. The scalp lesions extended up to the hairline and an Auspitz sign was documented as positive. She also reported scalp sweating and intermittent itching. Relevant mental characteristics included marked anger with a tendency to throw things, fears related to crossing roads, darkness and being alone, and a close attachment to her father. Family history included maternal allergy, paternal skin peeling, and a grandmother with pulmonary fibrosis. She had previously experienced breathing difficulty but no specific current medication was documented.
InterventionIndividualized homoeopathic treatment was prescribed based on the totality of symptoms. The documented regimen included Calcarea carbonica 200C, Mezereum 200C, and Kali sulphuricum 6X.
OutcomeDuring follow-up, the quantity of dandruff and intensity of itching progressively decreased. By June 2026, itching was reported to be absent except occasionally over the frontal scalp. In August 2026, dandruff was documented as substantially reduced compared with baseline, although residual flakes and dryness remained. Treatment adherence was noted to be inconsistent during part of the follow-up.
ConclusionThis case documents improvement in scalp flaking and pruritus during individualized homoeopathic management. Because this is a single uncontrolled case, the observed improvement cannot establish treatment efficacy or causality. The case highlights the importance of detailed clinical characterization, individualized prescribing and objective longitudinal follow-up.
Downloads
References
Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D, et al. The CARE guidelines: consensus-based clinical case reporting guideline development. J Clin Epidemiol. 2014;67(1):46-51. (PubMed)
Riley DS, Barber MS, Kienle GS, Aronson JK, von Schoen-Angerer T, Tugwell P, et al. CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol. 2017;89:218-235. (PubMed)
van Haselen RA. Homeopathic clinical case reports: development of a supplement (HOM-CASE) to the CARE clinical case reporting guideline. Complement Ther Med. 2016;25:78-85. (PubMed)
National Institute for Health and Care Excellence. Psoriasis: assessment and management. NICE guideline CG153. London: NICE; 2012, updated 2025. (NICE)
Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323(19):1945-1960.

